SRT2183 impairs ovarian cancer by facilitating autophagy.

Aging
Tingting SunGuofen Yang

Abstract

The 5-year survival rate of ovarian cancer patients is only 47%, and developing novel drugs for ovarian cancer is needed. Herein, we evaluated if and how SRT2183, a sirtuin-1 activator, impairs the ovarian cancer cells. OVCAR-3 and A2780 cells were treated with SRT2183. Cell viability was measured by cell counting kit-8 assay and clonogenic assay. Apoptosis was determined by flow cytometry with Annexin V and propidium iodide. The level of autophagy was evaluated by western blot and immunofluorescence. The activities of AKT/mTOR/70s6k and MAPK signaling pathway were measured by immunoblot. SRT2183 inhibited the growth of ovarian cancer cells, increased the accumulation of BAX, cleaved-caspase 3 and cleaved-PARP, and decreased the level of anti-apoptotic Bcl-2 and Mcl-1. SRT2183 increased the LC3II level, and enhanced the degradation of p62/SQSTM1. SRT2183 increased the formation of GFP-LC3 puncta and induced the maturation of autophagosome. Interestingly, knockdown of autophagy related 5 and 7 significantly impaired the anti-carcinoma activity of SRT2183, implying that SRT2183 impaired the ovarian cancer cells by inducing autophagy. SRT2183 decreased the accumulation of p-Akt, p-mTOR and p-70s6k, and activated the p38 MAPK signa...Continue Reading

References

Mar 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Li YuMichael Lenardo
Nov 9, 2007·Apoptosis : an International Journal on Programmed Cell Death·Andrew Thorburn
Mar 30, 2011·Journal of Visualized Experiments : JoVE·Haloom RafehiTom C Karagiannis
Mar 22, 2014·Annals of the Rheumatic Diseases·Yue ZhangMohit Kapoor
Feb 25, 2015·Nature Reviews. Clinical Oncology·Alpa M NickAnil K Sood
Apr 25, 2015·Nature Reviews. Cancer·Samuel AparicioAndrew L Kung
Nov 14, 2015·Autophagy·Michael J Munson, Ian G Ganley
Jul 29, 2017·Nature Reviews. Cancer·Jean M Mulcahy LevyAndrew Thorburn
Aug 12, 2017·Cancer Treatment Reviews·Jole VentrigliaChiara Della Pepa
Aug 19, 2017·Journal of Cancer·Dietmar ZechnerBrigitte Vollmar
Aug 22, 2017·The Korean Journal of Internal Medicine·Jin Young KimHong Suk Song
Aug 29, 2017·International Journal of Molecular Sciences·Saori R Yoshii, Noboru Mizushima
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
May 18, 2019·CA: a Cancer Journal for Clinicians·Stephanie LheureuxAmit M Oza
Jun 14, 2019·Journal of Advanced Research·Xianbin ZhangDietmar Zechner
Aug 23, 2019·Cancer Discovery·Ravi K AmaravadiJayanta Debnath
Oct 2, 2019·Frontiers in Cell and Developmental Biology·Kathrin Schmeisser, J Alex Parker
Oct 11, 2019·Human Reproduction Update·N SpearsF G Klinger
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Sarah L ColeridgeJo Morrison
Jan 9, 2020·Journal of Hematology & Oncology·Go J Yoshida

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
transmission electron microscopy
xenograft
Fluorescence

Software Mentioned

SPSS

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis